New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
09:06 EDTNUVA, STJ, DGX, ABCO, FLDM, CMN, THOR, ELGX, BSXPiper Jaffray's technical analyst holds an analyst/industry conference call
Technical Analyst Johnson provides a technical review of the firm's Medical Technology covered universe ahead of 4Q results on an Analyst/Industry conference call to be held on January 10 at 10 am.
News For ABCO;BSX;CMN;DGX;ELGX;FLDM;STJ;THOR;NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 27, 2015
07:57 EDTSTJAbbott spokesman says company not making offer for St. Jude, Bloomberg reports
The spokesperson's statement to Bloomberg follows a report earlier this morning from Financial Times that claimed Abbott (ABT) is prepping a takeover offer for St. Jude Medical (STJ) that would value the latter at $25B.
07:51 EDTSTJ, THORThoratec volatility low into report Abbott prepping offer for St. Jude Medical
Thoratec (THOR) September call option implied volatility is at 10, October is at 6; compared to its 52-week range of 8 to 54 suggesting decreasing price movement into reports Abbott (ABT) is preparing a bid for St. Jude Medical (STJ). In July St. Jude Medical and Thoratec approved an agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash. The deal is scheduled to close in Q4.
07:45 EDTSTJAbbott volatility up into report prepping takeover offer for St. Jude Medical
Subscribe for More Information
07:39 EDTSTJSt. Jude Medical volatility up, Abbott prepping $25B takeover offer FT reports
St. Jude Medical (STJ) September call option implied volatility is at 29, October is at 27; compared to its 52-week range of 17 to 36; suggesting slightly larger near term price movement into Abbott (ABT) is prepping a takeover offer that would value the company at $25B, sources tell The Financial Times.
06:57 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
06:56 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
06:12 EDTBSXBoston Scientific upgraded to Buy on valuation at Goldman
Subscribe for More Information
August 26, 2015
16:14 EDTFLDMFluidigm initiated with a Hold at Cantor
Subscribe for More Information
09:20 EDTFLDMFluidigm has negative read through from Becton Dickinson deal, says Leerink
Subscribe for More Information
August 25, 2015
08:36 EDTABCOThe Advisory Board weakness has created 'great entry point,' says Oppenheimer
Oppenheimer believes that the recent weakness in The Advisory Board has created "a great entry point." The firm says that the execution of the company's recently acquired Royall unit will probably negatively impact The Advisory Board's results. However, the firm thinks that the company's core healthcare segment, which it says accounts for 80% of the company's revenues, "is doing very well." Oppenheimer keeps a $61 price target and Outperform rating on the shares.
07:54 EDTSTJSt. Jude Medical management to meet with Oppenheimer
Subscribe for More Information
07:02 EDTNUVANuVasive exploring locations to build medical device facility
Subscribe for More Information
August 24, 2015
16:32 EDTBSXBoston Scientific announces CE Mark for MRI labeling for ICD, CRT-D systems
Boston Scientific has received CE Mark on magnetic resonance imaging conditional labeling for the current family of EL and MINI implantable cardioverter defibrillator and the X4 cardiac resynchronization therapy defibrillator systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.
09:45 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:31 EDTSTJSt. Jude Medical receives CE Mark for MRI labeling for Prodigy MRI system
Subscribe for More Information
08:29 EDTNUVA, THORWilliam Blair to hold a field trip
Subscribe for More Information
07:08 EDTABCOThe Advisory Board outlook has improved, says SunTrust
Subscribe for More Information
06:39 EDTTHORThoratec downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
06:19 EDTTHORThoratec downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Thoratec (THOR) to Hold from Buy ahead of the closing of its merger transaction with St. Jude Medical (STJ), which is expected to close by year-end.
August 21, 2015
08:50 EDTSTJ, THORThoratec announces end of 'go shop' period in merger agreement with St. Jude
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use